Unique techniques and the speed of drug discovery are two critical factors for biomedical research and health care, which importantly includes cancer research and oncology, where the potential applications are vast. These include detection and diagnosis of cancer, subtype classification, optimization of cancer treatment and identification of new therapeutic targets in drug discovery.
The development of rabbit monoclonal antibody technology provides an alternative source of monoclonal antibodies with higher specificity and less cost for the development of routine targeted therapy against cancers. In addition, integrated with the platform of kit development for drug safety monitoring, further accelerating the speed of drug discovery
- Optimization of clinical treatments and identification of new therapeutic targets
- Recent developments in monoclonal antibody technology
